ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 66 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285,853 | -35.6% | 48,286 | -19.3% | 0.00% | – |
| Q2 2023 | $444,206 | -52.9% | 59,866 | -40.1% | 0.00% | – |
| Q1 2023 | $943,914 | +119.0% | 99,885 | +146.8% | 0.00% | – |
| Q4 2022 | $431,037 | +16.5% | 40,473 | -19.3% | 0.00% | – |
| Q3 2022 | $370,000 | +58.1% | 50,172 | +3.1% | 0.00% | – |
| Q2 2022 | $234,000 | +125.0% | 48,655 | +138.4% | 0.00% | – |
| Q1 2022 | $104,000 | -43.5% | 20,408 | -33.2% | 0.00% | – |
| Q4 2021 | $184,000 | -52.8% | 30,569 | -30.5% | 0.00% | – |
| Q3 2021 | $390,000 | +129.4% | 43,972 | +104.6% | 0.00% | – |
| Q2 2021 | $170,000 | +385.7% | 21,489 | +368.3% | 0.00% | – |
| Q1 2021 | $35,000 | +34.6% | 4,589 | +39.5% | 0.00% | – |
| Q4 2020 | $26,000 | -92.0% | 3,289 | -90.3% | 0.00% | – |
| Q3 2020 | $327,000 | – | 33,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sentinus, LLC | 149,050 | $1,408,523 | 0.47% |
| Intrepid Financial Planning Group LLC | 19,000 | $179,550 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $113,400 | 0.06% |
| Interchange Capital Partners, LLC | 11,413 | $107,853 | 0.06% |
| Virtu Financial LLC | 21,650 | $205 | 0.02% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 15,000 | $141,750 | 0.02% |
| J. Goldman & Co LP | 42,228 | $399,055 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $604,479 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 46,311 | $437,639 | 0.01% |
| 683 Capital Management, LLC | 16,000 | $151,200 | 0.01% |